Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BGG492 in Acute Migraine
NCT00892203Phase 2Completed
- Sponsor
- Novartis
- Start
- Apr 2009
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of selurampanel in migraine, sponsored by Novartis. Started Apr 2009; status: completed.
02
Drugs
selurampanel
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00892203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00892203.